Fluvoxamine Mediates Specific, Early, and Delayed SARS-CoV-2 Protection through Antioxidant and Cytoprotective Pathways via Sigma-1 Receptor Agonism
-
Published:2022-09-18
Issue:
Volume:
Page:
-
ISSN:2228-5881
-
Container-title:Advanced Pharmaceutical Bulletin
-
language:en
-
Short-container-title:Adv Pharm Bull
Author:
Papadopoulos KonstantinosORCID,
Papadopoulou AlexandraORCID,
Aw Tar ChoonORCID
Publisher
Maad Rayan Publishing Company
Subject
General Pharmacology, Toxicology and Pharmaceutics,Pharmaceutical Science